Belviq Cancer Lawsuit Attorney
On February 13, 2020, the U.S. Food and Drug Administration (FDA) announced a voluntary recall of the prescription drug Belviq after studies revealed elevated cancer risks among patients taking it. Belviq, manufactured by Eisai, Inc., is a prescription drug prescribed primarily for overweight and obese patients struggling to lose weight.
If you or a loved one has used the drug Belviq and was diagnosed with cancer, you may be entitled to compensation from the drug manufacturer. Gersowitz Libo & Korek, P.C. is currently investigating and accepting claims on behalf of any individuals who have been diagnosed with cancer after having taken Belviq. For more information or to schedule a complimentary consultation with one of our New York Belviq lawsuit attorneys, please call Gersowitz Libo & Korek, P.C. at 1-646-798-1535.
What Is Belviq and How Does It Work?
Belviq (Lorcasein) is a prescription-only medication manufactured by Eisai, Inc. The drug was approved by the FDA in 2012. This drug was primarily prescribed for patients dealing with extreme weight loss and obesity.
The active ingredient, lorcaserin, facilitates weight loss in patents by altering signals in their brain to trigger loss of appetite and hunger. These simple chemical changes increases feeling of fullness – convincing the brain and body to reduce the intake of calorie and consume much less than the individual normally would.
Belviq was available to patients in two forms:
- Belviq – a 10mg tablet to be taken twice a day
- Belviq XR – this was an extended-release version with a much higher does than required only a single daily dose
The Dangers of Belviq
The concern over the weight loss drug, Belviq, is not recent. The FDA had previously expressed concerns regarding the safety of the drug prior to its approving it. In 2007, Eisai found that testing Belviq on rats resulted in an increased rate of tumors. Despite these concerning results, the FDA still continued with its approval of the drug – but only conditioned upon the manufacturer’s continuous testing to further monitor and verify the safety of the drug.
Eisai, Inc. complied with a double-blind, placebo-controlled clinical testing trial of Belviq that involved 12,000 participants. The trial initially tested for the risk of any heart-related problems. Some of the participants were given the actual drug, while others were administered a placebo.
Possible Types of Cancer Linked to Belviq
According to research, individuals who had taken Belviq had an increased risk of developing certain cancers compared to those taking a placebo. The cancers linked to the drug include:
- Pancreatic cancer
- Colorectal cancer
- Lung cancer
Additional research revealed that the longer an individual took Belviq, the higher the risk was for developing these types of cancers. Furthermore, the FDA stated that the risks outweighed the benefits, and asked for the voluntary recall. Further, they advised healthcare professionals to stop prescribing the medication to newer patients, in addition to reaching out to previous Belviq users and notifying them of the recall.
Even before the risk of cancer was known, there was a long list of side effects associated with Belviq. The side effects of this drug included:
- Dry mouth
- Back pain
FDA’s Advice for Patients After Recall
According to FDA recommendations, any individual who is still taking Belviq should immediately stop. If you are a patient who was previously taking the drug, it is recommended that you immediately consult with your doctor to discuss any alternative weight-loss solutions.
Moreover, the FDA recommends that individuals who are still in possession of Belviq should immediately dispose of the pills in a safe manner. When disposing a drug, it is best to take it to a drug take back location. However, if that is not a possible option, you may also dispose of any Belviq in your standard trash as follows:
- Mix pills with any unappetizing substance, such as cat litter or dirt
- Do NOT crush the pills to minimize environmental contamination
- Place the mixture in a sealed plastic bag
- Throw the bag away in your household garbage
You should also remove any personal or sensitive information from the pill bottle to minimize the risk of theft identity.
Who Is Eligible for a Belviq Recall Lawsuit?
If you or a loved one has taken Belviq and have been diagnosed with any type of cancer, you may be entitled to monetary compensation from the drug manufacturer, Eisai, Inc. You should immediately consult with a New York
Belviq lawsuit attorney if you:
- Have taken Belviq or Belviq XR regularly for at least 3 months.
- Were diagnosed with pancreatic, colorectal, or lung cancers at least 6 months after your first use of the drug.
- Were younger than 60 years old at the time of the cancer diagnosis.
If you meet any of these requirements, you should discusse your case and the possibility for compensation with an attorney. However, even if you do not meet all these criteria, you should still speak with an attorney to determine if there is any legal recourse.
Take Legal Action
Gersowitz Libo & Korek, P.C. is currently investigating legal claims involving victims who have cancer after taking Belviq
If you or someone you care about has been diagnosed with cancer after taking the prescription drug Belviq, you may be entitled to compensation. To protect your legal rights and get the full money damages you are entitled to, you need to immediately consult with an experienced New York Belviq lawsuit attorney.